United States · FDA National Drug Code directory
TAVNEOS
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73556-168_35c096c8-3581-4d09-b01c-d6e514e0c836
- Product NDC
- 73556-168
- Form
- CAPSULE
- Composition / generic term
- avacopan
- Labeler
- ChemoCentryx, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20211018
- Source listing expiry
- 20271231
Source-listed ingredients
- AVACOPAN — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-01) / 180 CAPSULE in 1 BOTTLE, PLASTIC · 73556-168-01
- 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-02) / 30 CAPSULE in 1 BOTTLE, PLASTIC · 73556-168-02
- 1 BOTTLE, PLASTIC in 1 CARTON (73556-168-96) / 30 CAPSULE in 1 BOTTLE, PLASTIC · 73556-168-96
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →